PAR23 COST-UTILITY OF ABATACEPT, A NEW BIOLOGIC TREATMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS WHO FAILED ANTI-TNF THERAPY

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64938-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)64938-8/fulltext
Title : PAR23 COST-UTILITY OF ABATACEPT, A NEW BIOLOGIC TREATMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS WHO FAILED ANTI-TNF THERAPY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64938-8&doi=10.1016/S1098-3015(10)64938-8
First page :
Section Title :
Open access? : No
Section Order : 99
Categories :
Tags :
Regions :
ViH Article Tags :